Clinical Trials in Tennessee

Showing 2101-2120 of 17,345 trials

TVMR With the INNOVALVE System Trial - Early Feasibility Study

NCT04919980

Study to evaluate the safety and performance of the INNOVALVE system

Mitral Valve Regurgitation (Degenerative or Functional)

Edwards Lifesciences65 participantsStarted Sep 2022

Los Angeles, California, United States • Naples, Florida, United States • Atlanta, Georgia, United States +14 more locations

COMPLETEDPhase 329 miles

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

NCT04294810

The purpose of the study is to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab in participants with previously untreated locally advanced, unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC), with no epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) translocation. Eligible participants will be randomized in a 1:1 ratio to receive either tiragolumab plus atezolizumab or placebo plus atezolizumab.

Non-Small Cell Lung Cancer

Hoffmann-La Roche620 participantsStarted Mar 2020

Denver, Colorado, United States • New Haven, Connecticut, United States • St. Petersburg, Florida, United States +131 more locations

TVMR With the INNOVALVE System Trial - Early Feasibility Study

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

Find Trials by Condition in Tennessee

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

A Study of PHN-010 in Patients With Advanced Solid Tumors

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

R-3750 in Patients With Mild to Moderate Ulcerative Colitis